Distinct Effects of Tissue-Type Plasminogen Activator and SMTP-7 on Cerebrovascular Inflammation Following Thrombolytic Reperfusion

A Novel Embolic Model of Cerebral Infarction and Evaluation of Stachybotrys microspora Triprenyl Phenol-7 (SMTP-7), a Novel Fungal Triprenyl Phenol Metabolite

(2010) Terumasa Hashimoto et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice

(2010) Keita Shibata et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

m-Calpain antagonizes RhoA overactivation and endothelial barrier dysfunction under disturbed shear conditions

(2009) Takuro Miyazaki et al.   CARDIOVASCULAR RESEARCH

Leukocyte Recruitment and Ischemic Brain Injury

(2009) Gokhan Yilmaz et al.   NEUROMOLECULAR MEDICINE

Tissue Plasminogen Activator Enhances the Hypoxia/reoxygenation-induced Impairment of the Blood–brain Barrier in a Primary Culture of Rat Brain Endothelial Cells

(2008) Takeshi Hiu et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Photothrombosis ischemia stimulates a sustained astrocytic Ca2+signalingin vivo

(2008) Shinghua Ding et al.   GLIA

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic

(2008) Manuel Yepes et al.   TRENDS IN NEUROSCIENCES